New insights into a protein that can block or help immune cells from attacking tumour cells in triple-negative breast cancer
Research newsResearch from Dr Oliver Pearce, Dr Priyanka Hirani and their team at Barts Cancer Institute, have discovered that different forms of a protein called Versican can either block, or support, the entry of cancer-killing immune cells into tumours in triple-negative breast cancer (TNBC). TNBC is one of the most challenging types of breast cancer to …
Read more